CPT® Code 82252

Official Description

Bilirubin; feces, qualitative

Common Language Description

A laboratory test known as the bilirubin feces qualitative test (CPT® Code 82252) is conducted to identify the presence of bilirubin in feces. Bilirubin is a pigmented waste product that is generated during the breakdown of red blood cells (RBCs). This process involves the conversion of hemoglobin from the RBCs into bilirubin, which is initially in a non-water soluble form known as unconjugated bilirubin. This unconjugated bilirubin is then transported to the liver, where it undergoes a transformation by attaching to sugar molecules, resulting in conjugated bilirubin. The conjugated form of bilirubin is water soluble, allowing it to be excreted from the liver into the small intestine. In the small intestine, bilirubin is further metabolized and ultimately eliminated from the body through feces, where it is found in the form of stercobilin. The qualitative test for fecal bilirubin is particularly significant in the diagnosis and monitoring of liver disorders, including conditions such as bile duct obstruction, as it helps to assess the liver's ability to process and excrete bilirubin effectively.

1. Indications

The bilirubin feces qualitative test (CPT® Code 82252) is indicated for various clinical scenarios where the assessment of bilirubin levels in feces is necessary. This test may be ordered to aid in the diagnosis and monitoring of liver disorders, particularly in the following situations:

Liver Disorders The test is utilized to evaluate liver function and detect potential liver diseases that may affect bilirubin metabolism.
Bile Duct Obstruction It helps in identifying obstructions in the bile duct, which can impede the normal flow of bile and bilirubin into the intestine.
Hemolytic Anemia The test may be used to assess conditions where there is increased breakdown of red blood cells, leading to elevated bilirubin levels.

2. Procedure

The procedure for conducting the bilirubin feces qualitative test involves several key steps to ensure accurate results. First, a sample of feces is collected from the patient, which must be handled and stored properly to prevent degradation of bilirubin. The sample is then subjected to a qualitative analysis, where it is tested for the presence of bilirubin. This is typically done using chemical reagents that react with bilirubin, producing a color change that can be visually assessed or measured using a spectrophotometer. The results are interpreted based on the intensity of the color change, indicating the presence or absence of bilirubin in the feces. It is essential that the laboratory personnel follow strict protocols during the testing process to maintain the integrity of the sample and ensure reliable results.

3. Post-Procedure

After the bilirubin feces qualitative test is completed, the results are analyzed and reported to the healthcare provider. Depending on the findings, further diagnostic testing or clinical evaluation may be warranted. If bilirubin is detected in the feces, it may indicate underlying liver dysfunction or bile duct obstruction, prompting additional investigations. Patients may not require specific post-procedure care, but it is important for healthcare providers to discuss the implications of the test results with the patient and determine any necessary follow-up actions or treatments based on the findings.

Short Descr	FECAL BILIRUBIN TEST
Medium Descr	BILIRUBIN FECES QUALITATIVE
Long Descr	Bilirubin; feces, qualitative
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
CLIA Waived (QW)	No
APC Status Indicator	Conditionally packaged laboratory tests
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	1
CCS Clinical Classification	233 - Laboratory - Chemistry and Hematology